The store will not work correctly when cookies are disabled.
5-(3-Furan-2-yl-allylidene)-2-selenoxo-dihydropyrimidine-4,6-dione
ID: ALA4160982
PubChem CID: 145956710
Max Phase: Preclinical
Molecular Formula: C11H8N2O3Se
Molecular Weight: 295.16
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1NC(=[Se])NC(=O)C1=C/C=C/c1ccco1
Standard InChI: InChI=1S/C11H8N2O3Se/c14-9-8(10(15)13-11(17)12-9)5-1-3-7-4-2-6-16-7/h1-6H,(H2,12,13,14,15,17)/b3-1+
Standard InChI Key: GQYQPTDJMBIDBU-HNQUOIGGSA-N
Molfile:
RDKit 2D
17 18 0 0 0 0 0 0 0 0999 V2000
14.8888 -9.0063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1810 -9.4138 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4691 -9.0063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4691 -8.1872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1810 -7.7797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8888 -8.1872 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.7613 -9.4138 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.1810 -6.9606 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.5965 -9.4138 0.0000 Se 0 0 0 0 0 2 0 0 0 0 0 0
12.7613 -7.7797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0535 -8.1872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3416 -7.7797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8870 -7.8558 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.6339 -8.1872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5487 -8.9999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7469 -9.1730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3394 -8.4611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
1 6 1 0
3 7 2 0
5 8 2 0
1 9 2 0
10 11 1 0
11 12 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
13 17 1 0
12 14 1 0
4 10 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 295.16 | Molecular Weight (Monoisotopic): 295.9700 | AlogP: ┄ | #Rotatable Bonds: ┄ |
Polar Surface Area: ┄ | Molecular Species: ┄ | HBA: ┄ | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): ┄ | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: ┄ | CX LogD: ┄ |
Aromatic Rings: ┄ | Heavy Atoms: ┄ | QED Weighted: ┄ | Np Likeness Score: ┄ |
References
1. Ramisetti SR, Pandey MK, Lee SY, Karelia D, Narayan S, Amin S, Sharma AK.. (2018) Design and synthesis of novel thiobarbituric acid derivatives targeting both wild-type and BRAF-mutated melanoma cells., 143 [PMID:29133035] [10.1016/j.ejmech.2017.11.006] |